Sorafenib Alone Versus Sorafenib Combined With Hepatic Arterial Chemoinfusion for Advanced HCC With Portal Vein Tumor Thrombosis: a Multicentre Randomised Controlled Trial
Latest Information Update: 16 Jan 2020
At a glance
- Drugs Fluorouracil (Primary) ; Folinic acid (Primary) ; Oxaliplatin (Primary) ; Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 03 Dec 2019 Status changed from active, no longer recruiting to completed.
- 03 Apr 2018 Planned End Date changed from 1 Dec 2018 to 1 Aug 2018.
- 03 Apr 2018 Status changed from recruiting to active, no longer recruiting.